E. Schacht

1.5k total citations
49 papers, 1.1k citations indexed

About

E. Schacht is a scholar working on Orthopedics and Sports Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, E. Schacht has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Orthopedics and Sports Medicine, 16 papers in Pathology and Forensic Medicine and 12 papers in Oncology. Recurrent topics in E. Schacht's work include Bone health and osteoporosis research (24 papers), Vitamin D Research Studies (16 papers) and Bone health and treatments (11 papers). E. Schacht is often cited by papers focused on Bone health and osteoporosis research (24 papers), Vitamin D Research Studies (16 papers) and Bone health and treatments (11 papers). E. Schacht collaborates with scholars based in Germany, Switzerland and United States. E. Schacht's co-authors include Laurent Dukas, J. D. Ringe, Florent Richy, H.B. Stähelin, Martin Runge, Jean‐Yves Reginster, P. Farahmand, Margaret L. Gourlay, H. Bischoff and Olivier Ethgen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Geriatrics Society and Tetrahedron Letters.

In The Last Decade

E. Schacht

46 papers receiving 1.0k citations

Peers

E. Schacht
Prema B. Rapuri United States
Nisrin O. Abu Elnour United States
J.-Y. Reginster Belgium
J. D. Ringe Germany
Aziz A. Alkatib United States
Chih‐Hsing Wu Taiwan
Nigel Gilchrist New Zealand
Kari Salovaara Finland
Jorge Nahás-Neto Brazil
J.-P. Bonjour Switzerland
Prema B. Rapuri United States
E. Schacht
Citations per year, relative to E. Schacht E. Schacht (= 1×) peers Prema B. Rapuri

Countries citing papers authored by E. Schacht

Since Specialization
Citations

This map shows the geographic impact of E. Schacht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schacht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schacht more than expected).

Fields of papers citing papers by E. Schacht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Schacht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schacht. The network helps show where E. Schacht may publish in the future.

Co-authorship network of co-authors of E. Schacht

This figure shows the co-authorship network connecting the top 25 collaborators of E. Schacht. A scholar is included among the top collaborators of E. Schacht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Schacht. E. Schacht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ringe, J. D., P. Farahmand, & E. Schacht. (2012). Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients. Rheumatology International. 33(3). 637–643. 10 indexed citations
2.
Schacht, E. & J. D. Ringe. (2010). Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass. Rheumatology International. 32(1). 207–215. 27 indexed citations
3.
4.
Ringe, J. D. & E. Schacht. (2009). Potential of alfacalcidol for reducing increased risk of falls and fractures. Rheumatology International. 29(10). 1177–1185. 11 indexed citations
5.
Schacht, E., et al.. (2008). Die Wirkung von Alfacalcidol auf den Muskel, das neuromuskuläre System, auf die Sturzgefahr und auf Frakuren. Journal für Kardiologie (Krause & Pachernegg GmbH). 15(3). 132–139. 2 indexed citations
6.
Richy, Florent, Laurent Dukas, & E. Schacht. (2008). Differential Effects of D-Hormone Analogs and Native Vitamin D on the Risk of Falls: A Comparative Meta-Analysis. Calcified Tissue International. 82(2). 102–107. 41 indexed citations
7.
Ringe, J. D. & E. Schacht. (2007). Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol. Rheumatology International. 28(2). 103–111. 16 indexed citations
8.
9.
Richy, Florent, E. Schacht, Olivier Bruyère, et al.. (2005). Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis. Calcified Tissue International. 76(3). 176–186. 103 indexed citations
10.
M, Ito, et al.. (2004). Bone Structure in vitro and in vivo in Animals and in Men - A view into the future. SHILAP Revista de lepidopterología. 11(3). 13–19. 10 indexed citations
11.
Schacht, E., J. D. Ringe, A. Dorst, Volker W. Rahlfs, & H. Faber. (2004). Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatology International. 24(2). 63–70. 35 indexed citations
12.
Dukas, Laurent, et al.. (2004). Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65�ml/min. Osteoporosis International. 16(2). 198–203. 41 indexed citations
13.
Dukas, Laurent, et al.. (2004). Alfacalcidol Reduces the Number of Fallers in a Community‐Dwelling Elderly Population with a Minimum Calcium Intake of More Than 500 Mg Daily. Journal of the American Geriatrics Society. 52(2). 230–236. 139 indexed citations
14.
Ringe, J. D. & E. Schacht. (2004). Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol. Rheumatology International. 24(4). 189–197. 27 indexed citations
15.
Dukas, Laurent, et al.. (2004). A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65�ml/min. Osteoporosis International. 16(3). 332–338. 60 indexed citations
16.
Schacht, E., et al.. (2003). Optimierung der Osteoporosetherapie - Kombination von Alfacalcidol und Alendronat. Journal für Kardiologie (Krause & Pachernegg GmbH). 10(4). 17–20. 1 indexed citations
17.
Ringe, J. D., et al.. (2000). Therapie der Glucocorticoid-induzierten Osteoporose mit Alfacalcidol/Kalzium und Vitamin D/Kalzium. Zeitschrift für Rheumatologie. 59(3). 176–182. 3 indexed citations
18.
Ringe, J. D., et al.. (1999). Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium. Calcified Tissue International. 65(4). 337–340. 58 indexed citations
19.
20.
Dambacher, M. A., et al.. (1997). Can the fast bone loss in osteoporotic and osteopenic patients be stopped with active vitamin D metabolites?. Calcified Tissue International. 60(1). 115–118. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prema B. Rapuri Breakdown of academic impact, for papers by Nisrin O. Abu Elnour Breakdown of academic impact, for papers by J.-Y. Reginster Breakdown of academic impact, for papers by J. D. Ringe Breakdown of academic impact, for papers by Aziz A. Alkatib Breakdown of academic impact, for papers by Chih‐Hsing Wu Breakdown of academic impact, for papers by Nigel Gilchrist Breakdown of academic impact, for papers by Kari Salovaara Breakdown of academic impact, for papers by Jorge Nahás-Neto Breakdown of academic impact, for papers by J.-P. Bonjour
Rankless by CCL
2026